About Bruker Corp. 
Bruker Corp.
Pharmaceuticals & Biotechnology
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.
Company Coordinates 
Company Details
40 MANNING RD , BILLERICA MA : 01821
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 100 Schemes (40.7%)
Foreign Institutions
Held by 204 Foreign Institutions (13.9%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Dr. Frank Laukien
Chairman of the Board, President, Chief Executive Officer
Dr. William Linton
Lead Independent Director
Ms. Bonnie Anderson
Independent Director
Ms. Cynthia Friend
Independent Director
Dr. Marc Kastner
Independent Director
Mr. John Ornell
Independent Director
Revenue and Profits:
Net Sales:
797 Million
(Quarterly Results - Jun 2025)
Net Profit:
4 Million
Pharmaceuticals & Biotechnology
USD 5,386 Million (Small Cap)
49.00
NA
27.41%
1.30
8.48%
2.99






